20 November 2023

Digital Clinical Trials in the Metaverse Future Scenario

Future Scenario Digital Clinical Trials in the Metaverse
Reading Time: < 1 minute
Project Lead/Expert: Peyman Moh
Project Scope: Future Scenario
Client/Partners:
GSK
Dassault Systems
Medidata Solutions
Status: Delivered
Date: 2023
Key Objectives:

  • Demonstrate the feasibility of conducting fully digital clinical trials within the Metaverse.
  • Utilize virtual twin technology to display real-time data and patient interactions.
  • Explore the benefits of a Metaverse-based clinical trial environment, including enhanced participant engagement, data accuracy, and trial efficiency.
  • Address regulatory, security, and privacy considerations in a fully digital trial setting.

Overview:

The Digital Clinical Trials in the Metaverse future scenario was a ground-breaking initiative aimed at revolutionising the traditional clinical trial process.

By leveraging the immersive and interactive capabilities of the Metaverse, the project sought to create a comprehensive digital environment for conducting clinical trials. This virtual setting allowed for real-time data collection and analysis through the use of virtual twins, simulating patient responses and drug effects accurately. The initiative focused on enhancing trial participation by making it more accessible and engaging for participants worldwide, thereby improving data quality and speeding up the trial process. Moreover, the project addressed the critical aspects of regulatory compliance, data security, and participant privacy, ensuring a safe and effective digital trial environment.

Key Outcomes:

  • Successfully implemented a clear scenario for conducting clinical trials within the Metaverse, showcasing the integration of virtual twin technology.
  • Demonstrated the potential for significant improvements in trial efficiency, participant engagement, and data accuracy.
  • Developed guidelines for maintaining regulatory compliance, security, and privacy within digital clinical trials.
  • Highlighted the scalability and flexibility of Metaverse-based trials in adapting to various clinical research needs.

Peyman Moh, a seasoned leader with over 20 years of experience in digital health and innovation, excels in transforming foresight into impactful realities. As the former Director of Digital Health & Innovation at GSK and founder of Foretell Innovation Lab, he has spearheaded major projects, established innovation accelerators, and provided advisory services. Renowned for his strategic foresight and ability to foster ecosystem collaborations, Peyman's expertise in future-back thinking and innovation lifecycle management positions him as a pivotal figure in navigating the rapidly evolving innovation landscape.